You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in API mitapivat

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing mitapivat

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Agios Pharmaceuticals Inc	PYRUKYND	mitapivat	71334-205	CELLULOSE, MICROCRYSTALLINE	2038-11-21
Agios Pharmaceuticals Inc	PYRUKYND	mitapivat	71334-205	CROSCARMELLOSE SODIUM	2038-11-21
Agios Pharmaceuticals Inc	PYRUKYND	mitapivat	71334-205	FD&C BLUE NO. 2	2038-11-21
Agios Pharmaceuticals Inc	PYRUKYND	mitapivat	71334-205	HYPROMELLOSE	2038-11-21
Agios Pharmaceuticals Inc	PYRUKYND	mitapivat	71334-205	LACTOSE MONOHYDRATE	2038-11-21
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for mitapivat

Excipient focus: CELLULOSE, MICROCRYSTALLINE

mitapivat drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

mitapivat drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 2

mitapivat drug variants containing FD&C BLUE NO. 2

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing FD&C BLUE NO. 2

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

mitapivat drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

mitapivat drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

mitapivat drug variants containing MANNITOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing MANNITOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

mitapivat drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

mitapivat drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

mitapivat drug variants containing TRIACETIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Agios Pharmaceuticals Inc	mitapivat	71334-205
Agios Pharmaceuticals Inc	mitapivat	71334-235
>Company	>Ingredient	>NDC

mitapivat drug variants not containing TRIACETIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.